Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof
US11739101B2 · kind B2 · utility
1Cited by
0References
40Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 5, 2021 |
| Grant date | Aug 29, 2023 |
| Priority date | — |
| Expiry date | May 5, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure provides bifunctional compounds as HPK1 degraders via ubiquitin proteosome pathway, and method for treating diseases modulated by HPK1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.